John Thomas Burns serves as Executive at Galena Biopharma, Inc., where they oversee executive responsibilities. Since joining the company, John Thomas Burns has executed 10 insider transactions totaling $4.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 3, 2025 involved transacting 58,592 shares valued at $87.9K.
John Thomas Burns currently holds 254,327 shares of Galena Biopharma, Inc. (GALE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Thomas Burns has been a net seller of GALE stock. They have purchased $0 and sold $4.5K worth of shares.
John Thomas Burns's most recent insider trade was on Dec 3, 2025, when they sold 58,592 shares at $1.50 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 6, 2023 | SLS | $3.2K | Other | 2,929 | $1.08 | Discretionary |
| Feb 2, 2023 | SLS | $0 | Award | 20,000 | $N/A | Discretionary |
| Dec 5, 2022 | SLS | $3.0K | Sale | 1,159 | $2.59 | Discretionary |
| Jan 31, 2022 | SLS | $0 | Award | 9,600 | $N/A | Discretionary |
| Dec 2, 2021 | SLS | $1.4K | Sale | 231 | $6.27 | Discretionary |
| Mar 4, 2021 | SLS | $0 | Award | 2,875 | $N/A | Discretionary |
| Mar 12, 2020 | SLS | $0 | Award | 15,000 | $N/A | Discretionary |
| Jul 1, 2016 | GALE | $3.4K | Other | 8,503 | $0.40 | Discretionary |